CANNULA, NASAL, OXYGE

The contract is for the procurement of 2 packages, each containing 50 nasal oxygen cannulas, for a total of 100 units, under NSN 6515-01-480-2308. Each cannula is an adult-sized, sterile, disposable, latex-free device with an 84-inch polyvinyl chloride tube, curved and flared tip, standard connector, and over-the-ear design. It is regulated by the FDA and must meet strict medical and packaging standards. The item must have a shelf life of 60 months, with no more than nine months elapsed between manufacture and delivery. Packaging and marking must comply with Medical Marking Standard No. 1, superseding MIL-STD-129, and preservation and packaging must conform to MIL-STD-2073-1E. Each unit must be sealed to prevent damage, and shipping containers must be commercial-grade, optimized for cost and safe transit to Fort Bragg, North Carolina. The delivery is FOB destination with a 20-day timeline from the solicitation award, and inspection and acceptance occur at the destination. The contract prohibits any variance in quantity, with a zero percent tolerance on delivery. Bidders must specify their source and part number, with recognized manufacturers listed including Cardinal Health, Teleflex, and Medline. Special requirements include compliance with DFARS cybersecurity safeguards, prohibition of hazardous materials like hexavalent chromium, restrictions on defense telecommunications equipment from certain foreign entities, and adherence to anti-trafficking and employment eligibility rules. All payment requests must be submitted electronically via WAWF, and the contracting officer must verify FDA regulatory status through EBS prior to award. The solicitation is open under DIBBS, with proposals due by May 26, 2026, and the NAICS code is 339112. Contract clauses covering sustainable products, disability employment, whistleblower rights, and subcontracting requirements for small businesses apply, with deviations granted under a blanket authorization for February 2026 clauses.